Clinical Trial Update: Study to Assess Pharmacokinetics, Safety, and Tolerability of XC-8 [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the pharmacokinetics, safety, and tolerability of XC-8 in asthma has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• XC-8

Snippet

Sponsor: EURRUS Biotech GmbH | Conditions: Asthma | Phase 1 | Status: COMPLETED